Clinical Pharmacy
Browse by
Collections in this community
Recent Submissions
-

Optimizing antibiotic dosing regimens for the treatment infection caused by Carbapenem Resistance Enterobacteriaceae in Thailand: the study of molecular resistance mechanisms, in vitro activity of monotherapy and combination therapy, and treatment outcomes
Collection: Theses (PH. D) - Clinical Pharmacy / ดุษฎีนิพนธ์ - เภสัชกรรมคลินิกType: Thesis(Silpakorn University, 25/11/2022)Carbapenem-resistant Enterobacterales (CRE) is a hospital-acquired pathogen with a high mortality rate and limited effective treatment options. The main objective was to design the optimal combination regimens for the ... -

Effectiveness and safety of angiotensin receptor-neprilysin inhibitor plus standard treatment versus standard treatment in heart failure
Collection: Theses (Master's degree) - Clinical Pharmacy / วิทยานิพนธ์ - เภสัชกรรมคลินิกType: Thesis(Silpakorn University, 4/7/2023)The main objective of this study was to compare the effectiveness between angiotensin receptor-neprilysin inhibitor (ARNI) plus standard treatment and standard treatment in heart failure with reduced ejection fraction ... -

Real-world effectiveness and safety of dabigatran in geriatric patients with atrial fibrillation
Collection: Theses (Master's degree) - Clinical Pharmacy / วิทยานิพนธ์ - เภสัชกรรมคลินิกType: Thesis(Silpakorn University, 4/7/2023)Dabigatran reduces ischemic stroke risk in patients with atrial fibrillation (AF). Bleeding risk in geriatric patients was higher than in younger patients, especially gastrointestinal bleeding. In this study, to compare ... -

Clinical outcomes of pharmacokinetic and pharmacodynamic meropenem dosing in critically ill patients with sepsis or septic shock
Collection: Theses (Master's degree) - Clinical Pharmacy / วิทยานิพนธ์ - เภสัชกรรมคลินิกType: Thesis(Silpakorn University, 4/7/2023)Prompt diagnosis and appropriate treatment reduce mortality. Meropenem is used as empirical therapy in patients with sepsis and septic shock. The optimal dose of meropenem should be considered for target pharmacokinetic/ ... -

Comparison of effectiveness between SGLT-2 inhibitors and non-SGLT-2 inhibitors for progression of chronic kidney disease in type 2 diabetes mellitus
Collection: Theses (Master's degree) - Clinical Pharmacy / วิทยานิพนธ์ - เภสัชกรรมคลินิกType: Thesis(Silpakorn University, 25/11/2022)Type 2 diabetes is a non-communicable disease, leading to chronic kidney disease. There is limited existing evidence of delayed progression kidney disease in patients with type 2 diabetes that received sodium glucose ...

